PRESS RELEASE published on 01/07/2025 at 10:13, 1 year 8 months ago Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech Sartorius Stedim Biotech S.A. releases half-year liquidity contract statement with details of shares and executed trades, complying with AMF regulations Liquidity Contract Shares Traded Volume Sartorius Stedim Biotech AMF Regulations
BRIEF published on 01/06/2025 at 11:08, 1 year 8 months ago Number of shares and voting rights of Sartorius Stedim Biotech Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
PRESS RELEASE published on 01/06/2025 at 11:03, 1 year 8 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. in Aubagne, France declares the total number of shares and voting rights in their issued capital according to regulations Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 01/06/2025 at 11:03, 1 year 8 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in their issued capital as of December 31, 2024 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech
BRIEF published on 12/03/2024 at 10:43, 1 year 9 months ago Sartorius Stedim Biotech Statement on Share Capital Share Capital Voting Rights Actions AMF Sartorius Stedim
PRESS RELEASE published on 12/03/2024 at 10:38, 1 year 9 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA in Aubagne, France declares total shares and voting rights as of November 30, 2024 Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 12/03/2024 at 10:38, 1 year 9 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in the issued capital as per regulatory requirements Voting Rights Shares Sartorius Stedim Biotech AMF Regulations French Regulatory News
BRIEF published on 11/04/2024 at 10:16, 1 year 10 months ago Sartorius Stedim Biotech Statement on Shares and Voting Rights Share Capital Voting Rights Actions AMF Sartorius Stedim
PRESS RELEASE published on 11/04/2024 at 10:11, 1 year 10 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital. Total shares: 97,330,405. Total voting rights: 165,567,396 Voting Rights Shares Sartorius Stedim Biotech Issued Capital French Regulatory News
BRIEF published on 10/17/2024 at 07:07, 1 year 11 months ago Sartorius Stedim Biotech: Unaudited results for the first nine months of 2024 Financial Results Sartorius Stedim Biotech Outlook 2024 Advanced Therapies Turnover
Published on 09/17/2026 at 12:00, 55 minutes ago Banyan Gold Intersects 1.05 g/t Gold over 52.8 metres and Bonanza-Grade Gold at Powerline Deposit, AurMac, Yukon, Canada
Published on 09/17/2026 at 10:00, 2 hours 55 minutes ago Eagle Plains Reports Additional Results from Drilling at the Don Lake Uranium Project, Saskatchewan
Published on 09/16/2026 at 23:45, 13 hours 10 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 15 hours 25 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 20 hours ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/17/2026 at 12:29, 26 minutes ago Electricity cloud market in transition: What options do customers have now?
Published on 09/17/2026 at 12:15, 40 minutes ago BDStar Hosted 2026 Ecosystem Partner Conference in Munich, Germany
Published on 09/16/2026 at 17:45, 19 hours 10 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 5 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 18 hours ago Report on the Combined General Meeting of the 10th of September 2026
